Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Corautus Genetics

Corautus Genetics is dedicated to the clinical development of new therapies for the treatment of patients with serious diseases, including severe cardiovascular and peripheral vascular disease. Our goal is to become a world leader in introducing genetic therapy products into medical practice. In the Fall of 2004, Corautus initiated the largest trial of its kind in the United States for angina patients who do not respond to currently available treatments


Contact Details:
75 Fifth Street, NW, Suite 313
Atlanta
Georgia
30308
United States of America
Tel:404.526.6200
Fax:
Email:
WWW:

www.corautus.com/




Loading...

Press Releases on Corautus Genetics:

BioPortfolio Logo
STRATHMANN BIOTEC AG AND QIAGEN SIGN MANUFACTURING AGREEMENT WITH 1st January, 1970 Strathmann Biotec
STRATHMANN BIOTEC AG AND QIAGEN SIGN MANUFACTURING AGREEMENT WITH CORAUTUS GENETICS FOR VEGF-2 PLASMID PRODUCTION Hamburg, Germany, January 8, 2004 Strathmann Biotec AG and Qiagen NV

BioNews Results for Corautus Genetics:

Hypercholesterolemia Genetics: Research on hypercholesterolemia genetics detailed by scientists at St. Louis University, Department of Pathology
NewsRX:  Nov 16 2009 5:43AM Matching: genetics
First Stem Cell Education Summit launched at Sheraton Denver
News-Medical.Net:  Nov 16 2009 6:07AM Matching: genetics
Mouse gene suppresses Alzheimer's plaques and tangles
Innovations Report:  Nov 16 2009 4:41AM Matching: genetics
Functional Genetics Announces Discovery of Target That Regulates Alzheimer's Disease
PR-USA.net:  Nov 15 2009 12:47PM Matching: genetics
Celiac Disease Genetics: Studies from University of Helsinki yield new information about celiac disease genetics
NewsRX:  Nov 15 2009 7:35AM Matching: genetics
Promote your company here: BioNewsCast - Press Release Distribution

View more Corautus Genetics news.

Corautus Genetics Clinical Trials:

To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter

Corautus Genetics (VEGF) Financial information Links from Barchart

VEGF Quote from from Barchart.com
VEGF Chart from from Barchart.com
VEGF Profile from from Barchart.com
VEGF Opinion from from Barchart.com

View more Corautus Genetics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 169 times since April 2007, the link to the organisation's website has been followed 27 times

Search for more companies in Atlanta

Search for more companies in Georgia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Corautus Genetics

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.